The five core values on which Affimed stands
To deliver life-changing medicines, we have the courage to be imaginative in our approach and we are convinced that change must be our constant.
How a dream-ending sports injury prompted our Chief Medical Officer to study medicine and take on cancer as his biggest opponent.
Arndt Schottelius, Chief Scientific Officer of Affimed, shares how courage is an essential ingredient in Affimed’s culture
Arndt Schottelius, Chief Scientific Officer of Affimed, shares how his personal experience fuels the company’s vision to improve therapeutics for cancer
Activating the innate immune system to revolutionize the treatment landscape for patients with CD30-positive lymphomas and EGFR-expressing solid tumors
Uniquely activating the innate immune system with AFM13 to destroy CD30-positive hematologic tumors
The immune system is rapidly emerging as a lead area of scientific discovery and holds vast potential for novel cancer treatments
Harnessing the power of the immune system has the potential to change the future of cancer treatment.
Like all illnesses and conditions – there is no one-size-fits-all approach to fighting cancer.
CD=cluster of differentiation; EGFR=epidermal growth factor receptor.